{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:46:23Z","timestamp":1676439983000},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/ced.13230","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T04:02:45Z","timestamp":1506052965000},"page":"925-926","source":"Crossref","is-referenced-by-count":1,"title":["A case of severe drug reaction secondary to alemtuzumab with successful re-exposure"],"prefix":"10.1093","volume":"42","author":[{"given":"S.","family":"Ngu","sequence":"first","affiliation":[{"name":"Centre for Dermatology; Monklands Hospital; Monkscourt Avenue Airdrie, Lanarkshire ML6 0JS UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Shaffrali","sequence":"additional","affiliation":[{"name":"Centre for Dermatology; Monklands Hospital; Monkscourt Avenue Airdrie, Lanarkshire ML6 0JS UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"10.1111\/ced.13230-BIB0001|ced13230-cit-0001","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.11551","article-title":"Phase II study of alemtuzumab in chronic lymphoproliferative disorders","volume":"98","author":"Ferrajoli","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/ced.13230-BIB0002|ced13230-cit-0002","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symtoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/ced.13230-BIB0003|ced13230-cit-0003","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/ced.13230-BIB0004|ced13230-cit-0004","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/ced.13230-BIB0005|ced13230-cit-0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/cup.12800","article-title":"Histopathologic spectrum of hypersensitivity reactions associated with anti-cd52 therapy (alemtuzumab)","volume":"43","author":"Clark","year":"2016","journal-title":"J Cutan Pathol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.13230","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.13230\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:45:17Z","timestamp":1676385917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/42\/8\/925\/6623247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.13230","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,21]]}}}